Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Apr;26(4):537-59.
doi: 10.1039/b714132g.

Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds

Affiliations
Review

Ribosomal peptide natural products: bridging the ribosomal and nonribosomal worlds

John A McIntosh et al. Nat Prod Rep. 2009 Apr.

Abstract

Ribosomally synthesized bacterial natural products rival the nonribosomal peptides in their structural and functional diversity. The last decade has seen substantial progress in the identification and characterization of biosynthetic pathways leading to ribosomal peptide natural products with new and unusual structural motifs. In some of these cases, the motifs are similar to those found in nonribosomal peptides, and many are constructed by convergent or even paralogous enzymes. Here, we summarize the major structural and biosynthetic categories of ribosomally synthesized bacterial natural products and, where applicable, compare them to their homologs from nonribosomal biosynthesis.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Examples of structurally diverse post-translationally modified RPs from bacteria
Figure 2
Figure 2. Generic biosynthetic route to bacterial RPs
In bacteria, a gene for a precursor peptide (orange) is often clustered with its modifying enzymes. The precursor peptide is translated, then posttranslationally modified by the encoded enzymes. Commonly, posttranslational modifications include both side chain modification and main chain modification such as proteolysis to generate the mature natural product.
Scheme 1
Scheme 1
Scheme 2
Scheme 2
Scheme 3
Scheme 3
Scheme 4
Scheme 4
Scheme 5
Scheme 5
Scheme 6
Scheme 6
Scheme 7
Scheme 7
Scheme 8
Scheme 8
Scheme 9
Scheme 9
Scheme 10
Scheme 10
Scheme 11
Scheme 11
Scheme 12
Scheme 12
Scheme 13
Scheme 13
Scheme 14
Scheme 14
Scheme 15
Scheme 15
Scheme 16
Scheme 16
Scheme 17
Scheme 17
Scheme 18
Scheme 18
Scheme 19
Scheme 19

References

    1. Gillor O, Kirkup BC, Riley MA. Advances in Applied Microbiology. 2004:129–146. - PubMed
    1. Duquesne S, Destoumieux-Garzon D, Peduzzi J, Rebuffat S. Nat. Prod. Rep. 2007;24:708–734. - PubMed
    1. Breukink E, de Kruijff B. Nat. Rev. Drug Discov. 2006;5:321–332. - PubMed
    1. Cotter PD, Hill C, Ross RP. Nat. Rev. Microbiol. 2005;3:777–788. - PubMed
    1. Willey JM, van der Donk WA. Annu. Rev. Microbiol. 2007;61:477–501. - PubMed

Publication types

MeSH terms